 Fabienne Gally
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid-Binding Proteins | 6 | 2023 | 67 | 2.390 |
Why?
| | TRPM Cation Channels | 2 | 2018 | 67 | 1.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 953 | 1.020 |
Why?
| | Smoke | 3 | 2017 | 132 | 0.950 |
Why?
| | PPAR gamma | 3 | 2022 | 182 | 0.910 |
Why?
| | Pneumonia, Mycoplasma | 4 | 2012 | 54 | 0.900 |
Why?
| | Neoplasm Proteins | 2 | 2019 | 421 | 0.840 |
Why?
| | Mycoplasma pneumoniae | 3 | 2012 | 53 | 0.830 |
Why?
| | Listeriosis | 2 | 2019 | 67 | 0.740 |
Why?
| | Immunity, Innate | 6 | 2017 | 805 | 0.720 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2025 | 2065 | 0.710 |
Why?
| | Listeria monocytogenes | 2 | 2019 | 123 | 0.710 |
Why?
| | Mucin-5B | 2 | 2022 | 218 | 0.650 |
Why?
| | Radiodermatitis | 1 | 2018 | 8 | 0.630 |
Why?
| | Macrophages | 3 | 2022 | 1466 | 0.590 |
Why?
| | Macrophages, Alveolar | 3 | 2021 | 380 | 0.560 |
Why?
| | Inflammation | 5 | 2023 | 2668 | 0.550 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2022 | 628 | 0.550 |
Why?
| | Glycoproteins | 3 | 2021 | 337 | 0.550 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 160 | 0.540 |
Why?
| | Cytokines | 4 | 2019 | 1987 | 0.510 |
Why?
| | Pneumonia | 3 | 2021 | 599 | 0.450 |
Why?
| | Lung | 8 | 2023 | 3752 | 0.440 |
Why?
| | Enhancer Elements, Genetic | 3 | 2025 | 179 | 0.420 |
Why?
| | Phosphoproteins | 2 | 2011 | 330 | 0.380 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 146 | 0.370 |
Why?
| | Bronchi | 1 | 2013 | 240 | 0.370 |
Why?
| | Epithelial Cells | 3 | 2017 | 1036 | 0.370 |
Why?
| | Mice, Knockout | 6 | 2021 | 2765 | 0.360 |
Why?
| | Down Syndrome | 1 | 2017 | 471 | 0.360 |
Why?
| | Pseudomonas aeruginosa | 2 | 2013 | 336 | 0.360 |
Why?
| | Mice | 17 | 2023 | 16644 | 0.350 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 213 | 0.350 |
Why?
| | Down-Regulation | 1 | 2013 | 634 | 0.340 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2008 | 38 | 0.310 |
Why?
| | Mice, Inbred C57BL | 7 | 2018 | 5284 | 0.300 |
Why?
| | Respiratory Hypersensitivity | 1 | 2008 | 65 | 0.300 |
Why?
| | Toll-Like Receptor 2 | 3 | 2013 | 110 | 0.270 |
Why?
| | Influenza, Human | 1 | 2013 | 601 | 0.270 |
Why?
| | Oxidative Stress | 1 | 2013 | 1192 | 0.270 |
Why?
| | Cells, Cultured | 7 | 2019 | 4010 | 0.260 |
Why?
| | Bacterial Load | 2 | 2019 | 67 | 0.260 |
Why?
| | Animals | 18 | 2023 | 34600 | 0.250 |
Why?
| | Binding Sites | 2 | 2021 | 1241 | 0.250 |
Why?
| | Allergens | 1 | 2008 | 383 | 0.240 |
Why?
| | RNA, Messenger | 3 | 2019 | 2676 | 0.240 |
Why?
| | Gene Expression Regulation | 4 | 2025 | 2508 | 0.240 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1423 | 0.220 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 23 | 0.220 |
Why?
| | Transcription Factors | 1 | 2011 | 1632 | 0.210 |
Why?
| | Cell Line | 2 | 2021 | 2737 | 0.210 |
Why?
| | Receptors, Glucocorticoid | 2 | 2025 | 148 | 0.200 |
Why?
| | Superoxide Dismutase | 2 | 2015 | 328 | 0.200 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.190 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.190 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.180 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 18 | 0.180 |
Why?
| | RNA | 2 | 2025 | 883 | 0.180 |
Why?
| | A549 Cells | 1 | 2021 | 58 | 0.180 |
Why?
| | NF-kappa B | 3 | 2019 | 652 | 0.180 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 33 | 0.180 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 380 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 244 | 0.180 |
Why?
| | Lipopolysaccharides | 3 | 2023 | 856 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 53 | 0.180 |
Why?
| | Genetic Predisposition to Disease | 4 | 2025 | 2267 | 0.170 |
Why?
| | Chromatin | 2 | 2021 | 478 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 940 | 0.170 |
Why?
| | Humans | 18 | 2025 | 129116 | 0.170 |
Why?
| | Th2 Cells | 2 | 2012 | 167 | 0.160 |
Why?
| | Blotting, Western | 2 | 2013 | 1169 | 0.160 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 538 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 190 | 0.160 |
Why?
| | Respiratory Mucosa | 2 | 2012 | 306 | 0.160 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2018 | 133 | 0.150 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1403 | 0.150 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.150 |
Why?
| | Models, Genetic | 1 | 2021 | 591 | 0.150 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2079 | 0.150 |
Why?
| | RNA Polymerase II | 1 | 2021 | 317 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2021 | 3953 | 0.140 |
Why?
| | Dexamethasone | 1 | 2019 | 340 | 0.140 |
Why?
| | Mucociliary Clearance | 2 | 2018 | 42 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 131 | 0.140 |
Why?
| | Asthma | 2 | 2025 | 2219 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 358 | 0.130 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 212 | 0.130 |
Why?
| | Disease Progression | 1 | 2023 | 2613 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 616 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2019 | 500 | 0.130 |
Why?
| | Cell Survival | 1 | 2019 | 1077 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2018 | 264 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 579 | 0.120 |
Why?
| | Protein Binding | 2 | 2018 | 2106 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1192 | 0.110 |
Why?
| | Skin | 1 | 2018 | 719 | 0.110 |
Why?
| | Base Sequence | 1 | 2017 | 2135 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2013 | 157 | 0.100 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 143 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 206 | 0.100 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1200 | 0.100 |
Why?
| | Ovalbumin | 2 | 2012 | 177 | 0.100 |
Why?
| | Antioxidants | 2 | 2014 | 543 | 0.100 |
Why?
| | Physical Conditioning, Animal | 1 | 2015 | 229 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 374 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 326 | 0.100 |
Why?
| | Heat Shock Transcription Factors | 1 | 2011 | 19 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2012 | 101 | 0.100 |
Why?
| | Adaptive Immunity | 1 | 2013 | 161 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 312 | 0.100 |
Why?
| | Tobacco Products | 1 | 2013 | 111 | 0.090 |
Why?
| | Bronchoalveolar Lavage | 1 | 2011 | 89 | 0.090 |
Why?
| | Risk Factors | 2 | 2023 | 9767 | 0.090 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 67 | 0.090 |
Why?
| | Cartilage, Articular | 1 | 2015 | 296 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2013 | 335 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 816 | 0.090 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 263 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2012 | 479 | 0.080 |
Why?
| | Chimera | 1 | 2008 | 59 | 0.080 |
Why?
| | Radiation Protection | 1 | 2008 | 37 | 0.080 |
Why?
| | Lead | 1 | 2008 | 56 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 367 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 288 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 268 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2008 | 329 | 0.070 |
Why?
| | Male | 5 | 2025 | 63194 | 0.070 |
Why?
| | Gene Expression | 2 | 2022 | 1462 | 0.070 |
Why?
| | Immunization | 1 | 2008 | 412 | 0.060 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 291 | 0.060 |
Why?
| | Lymph Nodes | 1 | 2008 | 467 | 0.060 |
Why?
| | Receptors, Drug | 1 | 2004 | 13 | 0.060 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2004 | 31 | 0.060 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2025 | 51 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 846 | 0.060 |
Why?
| | Potassium Channels | 1 | 2004 | 144 | 0.060 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 130 | 0.060 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 20 | 0.060 |
Why?
| | Signal Transduction | 2 | 2019 | 4838 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 231 | 0.050 |
Why?
| | Endothelium | 1 | 2023 | 107 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1741 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1230 | 0.050 |
Why?
| | alpha 1-Antitrypsin | 1 | 2023 | 103 | 0.050 |
Why?
| | Air Pollution | 1 | 2025 | 214 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 166 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 299 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 614 | 0.050 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.050 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.050 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2021 | 29 | 0.050 |
Why?
| | CD11b Antigen | 1 | 2021 | 59 | 0.050 |
Why?
| | Cell Size | 1 | 2021 | 87 | 0.050 |
Why?
| | Lectins | 1 | 2021 | 46 | 0.050 |
Why?
| | Monocytes | 1 | 2023 | 543 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 575 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 356 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 579 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 364 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 324 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 701 | 0.040 |
Why?
| | Female | 3 | 2025 | 68510 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 605 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 687 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1392 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1195 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5407 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 31 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 165 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1771 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 240 | 0.030 |
Why?
| | Arginine | 1 | 2014 | 259 | 0.030 |
Why?
| | Doxycycline | 1 | 2012 | 55 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2015 | 181 | 0.020 |
Why?
| | Running | 1 | 2015 | 228 | 0.020 |
Why?
| | Bone and Bones | 1 | 2015 | 302 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 639 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 627 | 0.020 |
Why?
| | Knee Joint | 1 | 2015 | 366 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 773 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1832 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 75 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1142 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 441 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6518 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 303 | 0.020 |
Why?
| | Sulfonylurea Receptors | 1 | 2004 | 5 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2012 | 2347 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 2004 | 149 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2004 | 338 | 0.010 |
Why?
| | Middle Aged | 1 | 2025 | 31074 | 0.010 |
Why?
| | Adult | 1 | 2025 | 35510 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1483 | 0.010 |
Why?
|
|
Gally's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|